Exclusive
Review Finds Just 31% of Consumer CBD Products Meet Label-Accuracy Standard
June 19, 2026
Review Finds Just 31% of Consumer CBD Products Meet Label-Accuracy Standard
The CB2 receptor, key in resistance to trastuzumab - Demócrata
June 19, 2026
The CB2 receptor, key in resistance to trastuzumab – Demócrata
June 19, 2026
CED Cannabis Science Digest: 3 Behavior and Safety Signals Worth Watching
How Medical Marijuana Recommendations Expand Care
June 19, 2026
How Medical Marijuana Recommendations Expand Care
What's in My Weed?
June 19, 2026
What’s in My Weed?
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 ...
June 19, 2026
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 …
ced pexels 30063102
June 18, 2026
CED Cannabis Science Digest: 3 Safety Signals Worth Watching
Ohio Tax Department Amends Adult-Use Cannabis Tax Rules
June 18, 2026
Ohio Tax Department Amends Adult-Use Cannabis Tax Rules
States Surpass $28 Billion in Tax Revenue From Legal Adult-Use Cannabis Sales
June 18, 2026
States Surpass $28 Billion in Tax Revenue From Legal Adult-Use Cannabis Sales
DEA Begins On-Site Inspections At Marijuana Businesses That Applied For Federal ...
June 18, 2026
DEA Begins On-Site Inspections At Marijuana Businesses That Applied For Federal …
What's in your weed? Study finds issues with labelling, tracking cannabis
June 18, 2026
What’s in your weed? Study finds issues with labelling, tracking cannabis
Only 1 in 3 Older Adults Screened for Cannabis, Drug Use
June 18, 2026
Only 1 in 3 Older Adults Screened for Cannabis, Drug Use
Cannabis caution as study finds increased psychosis risk for young people
June 18, 2026
Cannabis caution as study finds increased psychosis risk for young people
7 unexpected takeaways from the newest research on cannabis and brain effects
June 18, 2026
7 unexpected takeaways from the newest research on cannabis and brain effects
One Scientist's War To Understand Unregulated Drugs
June 18, 2026
One Scientist’s War To Understand Unregulated Drugs
When Back Pain Becomes Chronic: New Drug and Old-Fashioned Remedies Hold Promise
June 18, 2026
When Back Pain Becomes Chronic: New Drug and Old-Fashioned Remedies Hold Promise
Headed to a New York Dispensary This Weekend? Silly Nice Launches Concentrate Education Hub
June 18, 2026
Headed to a New York Dispensary This Weekend? Silly Nice Launches Concentrate Education Hub
ced unsplash iyeUwItlIPk 1
June 18, 2026
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
In the Mix: 7 More Articles — June 18, 2026
June 18, 2026
In the Mix: 7 More Articles — June 18, 2026
ced unsplash iyeUwItlIPk
June 18, 2026
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
ced unsplash NDOYHZ 98Rw 1
June 18, 2026
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
ced pexels 8442825 2
June 18, 2026
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows ...
June 18, 2026
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows …
ced pexels 8442825
June 18, 2026
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
7 unexpected takeaways from the newest research on cannabis and brain effects
June 18, 2026
7 unexpected takeaways from the newest research on cannabis and brain effects
ced unsplash mwpFjE1Bi0M
June 18, 2026
Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Relationships between cannabis use and mental disorders: assessing the coherence of ...
June 18, 2026
Relationships between cannabis use and mental disorders: assessing the coherence of …
ced unsplash NDOYHZ 98Rw
June 18, 2026
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 ...
June 18, 2026
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 …
ced unsplash IDM3n0LfNCY
June 18, 2026
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Fewer Employees Skip Work Days Where Medical Marijuana Is Legal, Especially For ...
June 18, 2026
Fewer Employees Skip Work Days Where Medical Marijuana Is Legal, Especially For …
Browse Tag

Clinical Commentary

161 Articles
ced pexels 8331646
GLP-1 Care

GLP-1 Receptor Agonist Resistance: Genetics & Clinical Use

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Receptor Agonist Resistance: Genetics & Clinical Use
April 20, 2026
7 Min Read

GLP-1 Clinical Relevance  #51Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservational StudyType 2 DiabetesSemaglutideGLP-1 Receptor…

ced pexels 18806858
GLP-1 Care

GLP-1 Receptor Agonist Benefits for Women’s Health

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Receptor Agonist Benefits for Women’s Health
April 20, 2026
7 Min Read

GLP-1 Clinical Relevance  #41Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservationalObesity TreatmentGLP-1 Receptor AgonistWomen’s…

ced pexels 9259964
GLP-1 Care

Tirzepatide Liraglutide Clinical Research | GLP-1 Evidence

CEDclinic_admin By CEDclinic_admin
Comments Off on Tirzepatide Liraglutide Clinical Research | GLP-1 Evidence
April 20, 2026
6 Min Read

GLP-1 Clinical Relevance  #42Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservationalObesity TreatmentTirzepatideWeight ManagementPrimary…

ced pexels 6669473
GLP-1 Care

GLP-1 Weight Loss Stigma: What the Research Reveals

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Weight Loss Stigma: What the Research Reveals
April 20, 2026
7 Min Read

GLP-1 Clinical Relevance  #43Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservational StudyObesity StigmaGLP-1 Receptor AgonistWeight Loss…

ced pexels 4076617
GLP-1 Care

Tirzepatide Clinical Research: Weight Loss Drug Economics

CEDclinic_admin By CEDclinic_admin
Comments Off on Tirzepatide Clinical Research: Weight Loss Drug Economics
April 20, 2026
7 Min Read

GLP-1 Clinical Relevance  #43Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservational AnalysisObesity PharmacotherapySemaglutideGLP-1 Receptor…

ced pexels 8442370
GLP-1 Care

GLP-1 Receptor Agonist Safety: Labs & Monitoring Guide

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Receptor Agonist Safety: Labs & Monitoring Guide
April 20, 2026
7 Min Read

GLP-1 Clinical Relevance  #47Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryObservationalObesityGLP-1 Receptor AgonistEndocrinologyAdults with…

Copyright 2026 — CED Clinic. All rights reserved.
CED Clinic
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU